Pathogen

Pathogen

  • Hymon® Coronavirus 229E/OC43/NL63/HKU1 Detection Kit

    Hymon® Coronavirus 229E/OC43/NL63/HKU1 Detection Kit

    This kit uses RT-PCR for in vitro detection of coronavirus 229E, OC43, NL63, and HKU1 in nasopharyngeal and/or oropharnygeal swam samples. Test results may serve as a reference for clinical evaluation of coronavirus 229E, OC43, NL62, and HKU1.

    Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.

    The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.

  • Hymon® MERS CoV Detection Kit

    Hymon® MERS CoV Detection Kit

    This kit uses RT-PCR for in vitro detection of MERS-CoV in nasopharyngeal and/or oropharyngeal swab samples. Test results may serve as a reference for clincial evaluation fo MERS-CoV infection. Based on high-efficiency enymatic processing technology, sample processing and purification are simultaneously completed in on etube to release and stabilize the pathogen nucleic acid. The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.

  • Hymon® Mycobacterium Tuberculosis Rifampin/ Isoniazid-Resistance Mutation Detection Kit

    Hymon® Mycobacterium Tuberculosis Rifampin/ Isoniazid-Resistance Mutation Detection Kit

    This kit uses RT-PCR for in vitro detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis in sample cultures.

    Positive rpoB results: the tuberculosis is resistant to rifampicin;
    Positive KatG, inhA results: the tuberculosis is resistant to isoniazid.

    Based on high-efficiency enzymatic processing technology, the test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.

  • Hymon® Mycobacterium Tuberculosis Detection Kit

    Hymon® Mycobacterium Tuberculosis Detection Kit

    This kit uses RT-PCR for in vitro detection of  Mycobacterium tuberculosis in nasopharyngeal and/or oropharyngeal swab, sputum and bronchoalveolar lavage fluid samples. Test results may serve as a reference for clinical evaluation of Mycobacterium tuberculosis infection.

    Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.

    The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.

  • Hymon® MULTONE™ Monkeypox Test Kit

    Hymon® MULTONE™ Monkeypox Test Kit

    Hymon® provides a quantitative PCR MULTONETM Monkeypox Test Kit for quick and sensitive detection of Monkeypox virus. This kit can detect specific nucleic acid fragments of the virus with Hymon’s innovative “one-step” method as fast as 30 minutes from sample to results. The reagent uses the company’s unique MoLock and DIDC technology, suitable for accurate diagnosis of related diseases. It has the characteristics of fast detection, high sensitivity, and high specificity, and is compatible with conventional fluorescent PCR platforms.

  • Hymon® COVID-19 Antigen Rapid Test Kit

    Hymon® COVID-19 Antigen Rapid Test Kit

    Hymon® COVID-19 antigen rapid test kit is a lateral flow immunoassay for the qualitative detection of SARS-COV-2 antigen (nucleocapsid protein) with nasal swabs or saliva during the acute phase of infection. It only takes 15 minutes to complete the test and non-invasive. Negative results do not rule out SARS CoV-2 infection, and should not be used as the sole basis for treatment. Molecular assay may be performed if necessary.